Nitropress
Valeant announces expanded discounts for Nitropress and Isuprel
May 17, 2016Manufacturing and Production, Sales and Marketing Isuprel, Nitropress, Valeant, discounts
Valeant Pharmaceuticals (NYSE: VRX) has stepped up its public relations campaign with an announcement of expanded discounts for Nitropress (nitroprusside) …
Valeant receives court writ over US drug pricing
October 15, 2015Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena
Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
